Ricmika 250mg Injection
Marketer
Biorika Healthcare
Salt Composition
Amikacin (250mg)
Overview Ricmika 250mg Injection
Cephalexin 250mg Injection combats a broad spectrum of bacterial infections, including those affecting the urinary tract, bones, joints, lungs (such as pneumonia), brain, and bloodstream. This antibiotic is also prophylactically administered to hospitalized patients to prevent infection. Its mechanism involves inhibiting bacterial growth. Administered intravenously (IV infusion) or via intramuscular injection by a healthcare professional, self-administration is strictly prohibited. Adherence to the prescribed dosage schedule, with evenly spaced intervals, is crucial. Complete the entire course of treatment, even with symptom improvement; premature cessation may result in recurrence or exacerbation of the infection. Common adverse effects include injection site reactions and elevated blood urea nitrogen (BUN). Persistent side effects or lack of improvement warrant immediate medical consultation. High doses may cause vertigo, nephrotoxicity (kidney damage), and ototoxicity (hearing loss). Strict adherence to physician instructions is essential, including regular monitoring of kidney function, hearing, and urine analysis. Use during pregnancy is contraindicated. Disclose pregnancy, pregnancy intentions, or breastfeeding to your doctor.
Uses of Ricmika 250mg Injection
Infections caused by bacteria
Major Benefits of Ricmika 250mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Ricmika 250mg Injection:
- Increased blood urea
- Injection site reactions (pain, swelling, redness)
How to use Ricmika 250mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
How Ricmika 250mg Injection works:
The injectable antibiotic Ricmika 250mg inhibits bacterial proliferation by disrupting the production of proteins crucial for bacterial survival.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse interactions between Ricmika 250mg Injection and alcohol consumption.
PregnancyCONSULT YOUR DOCTOR
Administering Ricmika 250mg Injection during pregnancy poses a confirmed risk to fetal development and is therefore contraindicated. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is mandatory.
Breast feedingSAFE IF PRESCRIBED
Lactation and Ricmika 250mg Injection pose no known safety risk. Research in humans indicates negligible transfer of the medication into breast milk, posing no apparent threat to the infant.
DrivingUNSAFE
The administration of Ricmika 250mg Injection can induce drowsiness, blurred vision, and dizziness, potentially impairing alertness. Driving should be avoided if these effects are experienced.
KidneyCAUTION
Individuals with impaired kidney function should use Ricmika 250mg Injection with careful monitoring. Dosage modification of Ricmika 250mg Injection may be necessary. Physician consultation is recommended.
LiverSAFE IF PRESCRIBED
The use of Ricmika 250mg Injection in patients with liver disease appears to pose minimal risk. Existing evidence indicates dose modification may be unnecessary for this patient group. However, physician consultation is advised.
What if you forget to take Ricmika 250mg Injection :
Should you forget a dose of Ricmika 250mg Injection, seek advice from your physician.
Facts to Know About Ricmika 250mg Injection
| Label | Value |
|---|---|
| Type of Compound | Amino glycoside antibiotics |
| Potential for Dependence | None. |
| Medication Category | Agents against infection |
| Mechanism of Action | Aminoglycoside antibiotics |
3,018 People bought this recently